• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡布特罗和间羟异丙肾上腺素的代谢及心血管效应

Metabolic and cardiovascular effects of carbuterol and metaproterenol.

作者信息

Sanders J P, Potter D E, Ellis S, Bee D E, Grant J A

出版信息

J Allergy Clin Immunol. 1977 Sep;60(3):174-9. doi: 10.1016/0091-6749(77)90121-x.

DOI:10.1016/0091-6749(77)90121-x
PMID:19514
Abstract

Metabolic and cardiovascular responses to selective beta-adrenergic bronchodilators, carbuterol and metaproterenol, were studied during an asymptomatic period in 8 male subjects with bronchial asthma diagnosed as mile to moderate. On separate days each individual received either placebo, carbuterol 2 mg, carbuterol 4 mg, or metaproterenol 20 mg orally in a double-blind fashion. Subsequently, metabolic and cardiovascular responses were measured periodically for 5 hr. Carbuterol 2 mg was indistinguishable from placebo except for small elevations of glucose at 3 and 4 hr. Carbuterol 4 mg produced significant increases in glucose, insulin, lactate, and free fatty acids as well as in pulse rate and arterial pulse pressure. Metaproterenol produced increases only in plasma glucose and insulin. The majority of patients reported drug-related side effects which were all mild, after taking either carbuterol 4 mg or metaproterenol 20 mg. Fewer subjective side effects were noted with carbuterol 2 mg. These findings indicate that a 2-mg dose of carbuterol can be administered to typical asthmatic subjects without significant subjective or objective side effects. The larger dose (4 mg) may be accompanied by a greater frequency of side effects.

摘要

在8名被诊断为轻度至中度支气管哮喘的男性受试者无症状期,研究了对选择性β-肾上腺素能支气管扩张剂卡布特罗和间羟异丙肾上腺素的代谢及心血管反应。在不同日期,每位受试者以双盲方式口服安慰剂、2毫克卡布特罗、4毫克卡布特罗或20毫克间羟异丙肾上腺素。随后,定期测量5小时内的代谢和心血管反应。2毫克卡布特罗与安慰剂无明显差异,仅在3小时和4小时血糖略有升高。4毫克卡布特罗使血糖、胰岛素、乳酸和游离脂肪酸以及脉搏率和动脉脉压显著升高。间羟异丙肾上腺素仅使血浆葡萄糖和胰岛素升高。大多数患者在服用4毫克卡布特罗或20毫克间羟异丙肾上腺素后报告了与药物相关的副作用,均为轻度。2毫克卡布特罗引起的主观副作用较少。这些发现表明,2毫克剂量的卡布特罗可用于典型哮喘患者,而无明显的主观或客观副作用。较大剂量(4毫克)可能伴随更高频率的副作用。

相似文献

1
Metabolic and cardiovascular effects of carbuterol and metaproterenol.卡布特罗和间羟异丙肾上腺素的代谢及心血管效应
J Allergy Clin Immunol. 1977 Sep;60(3):174-9. doi: 10.1016/0091-6749(77)90121-x.
2
Comparative metabolic and cardiovascular effects of carbuterol, isoproterenol, metaproterenol and salbutamol in the baboon.沙丁胺醇、异丙肾上腺素、间羟异丙肾上腺素和特布他林对狒狒代谢及心血管系统影响的比较
Horm Metab Res. 1980 Jul;12(7):323-7. doi: 10.1055/s-2007-996280.
3
Double-blind trial of oral carbuterol in bronchial asthma.口服卡布特罗治疗支气管哮喘的双盲试验。
Ann Allergy. 1977 Jul;39(1):12-7.
4
Carbuterol, fenoterol, orciprenaline, salbutamol and terbutaline per os in reversible obstructive chronic bronchitis.克仑特罗、非诺特罗、奥西那林、沙丁胺醇及特布他林口服治疗可逆性阻塞性慢性支气管炎。
Bull Eur Physiopathol Respir. 1976 Jul-Aug;12(4):545-53.
5
Carbuterol: a double-blind clinical trial comparing carbuterol and salbutamol.卡布特罗:一项比较卡布特罗与沙丁胺醇的双盲临床试验。
Curr Ther Res Clin Exp. 1976 Feb;19(2):170-9.
6
Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children.支气管哮喘中卡布特罗与异丙肾上腺素气雾剂疗法的肺量计比较。对28名成年人进行的双盲配对研究以及对18名儿童进行的双盲交叉研究。
Am Rev Respir Dis. 1976 Jul;114(1):79-86. doi: 10.1164/arrd.1976.114.1.79.
7
Double-blind crossover study of carbuterol and salbutamol in bronchial asthma.卡布特罗与沙丁胺醇治疗支气管哮喘的双盲交叉研究
J Int Med Res. 1981;9(4):261-7. doi: 10.1177/030006058100900405.
8
Bronchodilator and side effects of different modes of administration of metaproterenol: inhaled, oral, and in combination.间羟异丙肾上腺素不同给药方式(吸入、口服及联合用药)的支气管扩张作用及副作用
Am J Med Sci. 1986 Mar;291(3):168-74. doi: 10.1097/00000441-198603000-00005.
9
Bronchodilator effect of a new oral beta adrenoreceptor stimulant, Th1165a. A comparison with metaproterenol sulfate.新型口服β肾上腺素能受体兴奋剂Th1165a的支气管扩张作用。与硫酸间羟异丙肾上腺素的比较。
Chest. 1976 Oct;70(4):460-5. doi: 10.1378/chest.70.4.460.
10
Comparison of carbuterol and hexoprenaline aerosol in bronchial asthma.卡布特罗与己双肾上腺素气雾剂治疗支气管哮喘的比较
S Afr Med J. 1978 Apr 15;53(15):571-3.

引用本文的文献

1
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.哮喘和 COPD:聚焦β-激动剂——过去、现在和未来。
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.